MRIGLOBAL
DBA: MIDWEST RESEARCH INSTITUTE
KANSAS CITY, MISSOURI 641102241
Top Industries (NAICS)
| NAICS Code | Obligations | Awards |
|---|---|---|
| 541715 | $94.66M | 123 |
| 541690 | $23.66M | 26 |
| 541380 | $22.06M | 27 |
| 336211 | $13.57M | 4 |
| 541712 | $13.50M | 26 |
| 325412 | $6.91M | 40 |
| 611430 | $3.15M | 11 |
| 325411 | $1.31M | 11 |
| 541711 | $930K | 27 |
| 541714 | $284K | 24 |
Contract Awards
50 awards found
RESEARCH AND DEVELOPMENT PRODUCT STORAGE AND SHIPPING
MYCOBACTERIUM TUBERCULOSIS (MTB) QUALITY ASSESSMENT PROGRAM (TBQA)
(PHILIS) PLATFORM MODERNIZATIN: PURSUANT TO THE AUTHORITY OF 41 U.S.C.253(C) AS IMPLEMENTED BY FAR 6.302-1, THIS MODIFICATION INCREASES THE CEILING OF CLIN 0002 AND EXTENDS THE DELIVERY DATE TO 6/17/26 TO DEFINITIZE THE CHANGE ORDER ISSUED ON 9/30/25
MANUFACTURE OF CLINICAL GRADE EPSTEIN-BARR VIRUS VACCINE
DIAGNOSTIC TESTING IDIQ
TO ADMINISTRATIVELY DE-OBLIGATE UNEXPENDED AND EXPIRING FISCAL YEAR 2020 FUNDING IN ACCORDANCE WITH 31 U.S.C. SECTION 1552 (A), IN PREPARATION FOR SEPTEMBER 30, 2025, CLOSING OF THE PERIOD OF AVAILABILITY OF THESE FISCAL YEAR FUNDS.
THE PURPOSE OF THIS REQUIREMENT IS TO CONTRACT FOR API AND DILUENT
TO ADMINISTRATIVELY DE-OBLIGATE UNEXPENDED AND EXPIRING FISCAL YEAR 2020 FUNDING IN ACCORDANCE WITH 31 U.S.C. SECTION 1552 (A), IN PREPARATION FOR SEPTEMBER 30, 2025, CLOSING OF THE PERIOD OF AVAILABILITY OF THESE FISCAL YEAR FUNDS.
CHEMISTRY SERVICES
SLAUGENHAUPT-MGH DMFP FOR BPN36964 (PTC680)
EOI::{RADICAL TRANSPARENCY ABOUT WASTEFUL SPENDING}::EOI{BILATERAL MODIFICATION TO DESCOPE}
INFORMATION ANALYSIS CENTER MULTIPLE AWARD CONTRACT TASK ORDER PERFORMANCE WORK STATEMENT (PWS) RESEARCH, DEVELOPMENT, TEST AND EVALUATION FOR THE JOINT PROGRAM EXECUTIVE OFFICE FOR CHEMICAL, BIOLOGICAL, RADIOLOGICAL, AND NUCLEAR DEFENSE
INFORMATION ANALYSIS CENTER MULTIPLE AWARD CONTRACT TASK ORDER PERFORMANCE WORK STATEMENT (PWS) RESEARCH, DEVELOPMENT, TEST AND EVALUATION FOR THE JOINT PROGRAM EXECUTIVE OFFICE FOR CHEMICAL, BIOLOGICAL, RADIOLOGICAL, AND NUCLEAR DEFENSE
EVALUATION OF SHELF-LIFE OF SAMPLES OF INVESTIGATIONAL CLINICAL DRUG FORMULATIONS, TO INCLUDE PARENTERAL, ORAL, AND OTHER TYPES OF DOSAGE FORMS.
RESEARCH, DEVELOPMENT, TEST, EVALUATION, AND STRATEGIC INITIATIVES FOR JOINT PROGRAM EXECUTIVE OFFICE FOR CHEMICAL, BIOLOGICAL, RADIOLOGICAL, AND NUCLEAR DEFENSE
BIO-AMT-2301: IDIQ CONTRACT MANAGEMENT SUPPORT ACTIVITIES
EXERCISE OPTIONS 1,2,3,4
IDP PRODUCTION FOR THE KETAMINE PROGRAM-QUOTE # NIH-OLAO 0001
RESEARCH, DEVELOPMENT, TEST, EVALUATION, AND STRATEGIC INITIATIVES FOR JOINT PROGRAM EXECUTIVE OFFICE FOR CHEMICAL, BIOLOGICAL, RADIOLOGICAL, AND NUCLEAR DEFENSE
INFORMATION ANALYSIS CENTER MULTIPLE AWARD CONTRACT TASK ORDER PERFORMANCE WORK STATEMENT (PWS) RESEARCH, DEVELOPMENT, TEST AND EVALUATION FOR THE JOINT PROGRAM EXECUTIVE OFFICE FOR CHEMICAL, BIOLOGICAL, RADIOLOGICAL, AND NUCLEAR DEFENSE
CENTRALIZED CHEMOPREVENTIVE AGENT REPOSITORY AND CHEMISTRY SUPPORT
DRUG SHELF LIFE TESTING PERIOD OF PERFORMANCE 02/01/2023 - 07/31/2023
CENTRALIZED CHEMOPREVENTIVE AGENT REPOSITORY AND CHEMISTRY SUPPORT
CHEMISTRY SERVICES
RESEARCH, DEVELOPMENT, TEST, EVALUATION, AND STRATEGIC INITIATIVES FOR JOINT PROGRAM EXECUTIVE OFFICE FOR CHEMICAL, BIOLOGICAL, RADIOLOGICAL, AND NUCLEAR DEFENSE
INFORMATION ANALYSIS CENTER MULTIPLE AWARD CONTRACT TASK ORDER PERFORMANCE WORK STATEMENT (PWS) RESEARCH, DEVELOPMENT, TEST AND EVALUATION FOR THE JOINT PROGRAM EXECUTIVE OFFICE FOR CHEMICAL, BIOLOGICAL, RADIOLOGICAL, AND NUCLEAR DEFENSE
CHEMISTRY SERVICES
RESEARCH, DEVELOPMENT, TEST, EVALUATION, AND STRATEGIC INITIATIVES FOR JOINT PROGRAM EXECUTIVE OFFICE FOR CHEMICAL, BIOLOGICAL, RADIOLOGICAL, AND NUCLEAR DEFENSE
LABORATORY SUPPORT SERVICES
INFORMATION ANALYSIS CENTER MULTIPLE AWARD CONTRACT TASK ORDER PERFORMANCE WORK STATEMENT (PWS) RESEARCH, DEVELOPMENT, TEST AND EVALUATION FOR THE JOINT PROGRAM EXECUTIVE OFFICE FOR CHEMICAL, BIOLOGICAL, RADIOLOGICAL, AND NUCLEAR DEFENSE
INFORMATION ANALYSIS CENTER MULTIPLE AWARD CONTRACT TASK ORDER PERFORMANCE WORK STATEMENT (PWS) RESEARCH, DEVELOPMENT, TEST AND EVALUATION FOR THE JOINT PROGRAM EXECUTIVE OFFICE FOR CHEMICAL, BIOLOGICAL, RADIOLOGICAL, AND NUCLEAR DEFENSE
RESEARCH, DEVELOPMENT, TEST, EVALUATION, AND STRATEGIC INITIATIVES FOR JOINT PROGRAM EXECUTIVE OFFICE FOR CHEMICAL, BIOLOGICAL, RADIOLOGICAL, AND NUCLEAR DEFENSE
PORTABLE HIGH THROUGHPUT INTEGRATED LABORATORY IDENTIFICATION SYSTEMS (PHILIS) PLATFORM MODERNIZATION 2.0
RESEARCH, DEVELOPMENT, TEST, EVALUATION, AND STRATEGIC INITIATIVES FOR JOINT PROGRAM EXECUTIVE OFFICE FOR CHEMICAL, BIOLOGICAL, RADIOLOGICAL, AND NUCLEAR DEFENSE
CONTRACT EXTENSION, EXERCISE OP12
ONE ACQUISITION SOLUTION FOR INTEGRATED SERVICES PLUS (OASIS+) UNRESTRICTED MULTIPLE AGENCY CONTRACT (MAC)
NBAF CURRICULA DEVELOPMENT QM, TABLETOP, VIDEOS AND SDS
RESEARCH, DEVELOPMENT, TEST, EVALUATION, AND STRATEGIC INITIATIVES FOR JOINT PROGRAM EXECUTIVE OFFICE FOR CHEMICAL, BIOLOGICAL, RADIOLOGICAL, AND NUCLEAR DEFENSE
INFORMATION ANALYSIS CENTER MULTIPLE AWARD CONTRACT TASK ORDER PERFORMANCE WORK STATEMENT (PWS) RESEARCH, DEVELOPMENT, TEST AND EVALUATION FOR THE JOINT PROGRAM EXECUTIVE OFFICE FOR CHEMICAL, BIOLOGICAL, RADIOLOGICAL, AND NUCLEAR DEFENSE
NBAF CURRICULA DEVELOPMENT QM, TABLETOP, VIDEOS AND SDS
RESEARCH AND DEVELOPMENT PRODUCT STORAGE AND SHIPPING
INFORMATION ANALYSIS CENTER MULTIPLE AWARD CONTRACT TASK ORDER PERFORMANCE WORK STATEMENT (PWS) RESEARCH, DEVELOPMENT, TEST AND EVALUATION FOR THE JOINT PROGRAM EXECUTIVE OFFICE FOR CHEMICAL, BIOLOGICAL, RADIOLOGICAL, AND NUCLEAR DEFENSE
MYCOBACTERIUM TUBERCULOSIS (MTB) QUALITY ASSESSMENT PROGRAM (TBQA)
INFORMATION ANALYSIS CENTER MULTIPLE AWARD CONTRACT TASK ORDER PERFORMANCE WORK STATEMENT (PWS) RESEARCH, DEVELOPMENT, TEST AND EVALUATION FOR THE JOINT PROGRAM EXECUTIVE OFFICE FOR CHEMICAL, BIOLOGICAL, RADIOLOGICAL, AND NUCLEAR DEFENSE
RESEARCH, DEVELOPMENT, TEST, EVALUATION, AND STRATEGIC INITIATIVES FOR JOINT PROGRAM EXECUTIVE OFFICE FOR CHEMICAL, BIOLOGICAL, RADIOLOGICAL, AND NUCLEAR DEFENSE
PROCESS DEVELOPMENT OF TELACEBEC FOR TUBERCULOSIS
COST PLUS FIXED FEE AGNOSTIC THREAT DETECTION PROTOTYPE (ATDP) P00003: EXERCISE AND FULLY FUND OPTION 1/CLIN 1001/PHASE II IN THE AMOUNT OF $1,746,197.69. THE TOTAL OBLIGATED AMOUNT FOR CLIN 1001 INCREASES FROM $0 BY $1,746,197.69 TO $1,746,197.69.
MANUFACTURE OF PLASMID DNA DRUG SUBSTANCE AND DRUG PRODUCT
RESEARCH, DEVELOPMENT, TEST, EVALUATION, AND STRATEGIC INITIATIVES FOR JOINT PROGRAM EXECUTIVE OFFICE FOR CHEMICAL, BIOLOGICAL, RADIOLOGICAL, AND NUCLEAR DEFENSE
INFORMATION ANALYSIS CENTER MULTIPLE AWARD CONTRACT TASK ORDER PERFORMANCE WORK STATEMENT (PWS) RESEARCH, DEVELOPMENT, TEST AND EVALUATION FOR THE JOINT PROGRAM EXECUTIVE OFFICE FOR CHEMICAL, BIOLOGICAL, RADIOLOGICAL, AND NUCLEAR DEFENSE
Business Details
- UEI
- HKQHNFKNKL15
- CAGE Code
- 21165
- Address
- 425 VOLKER BLVD
KANSAS CITY, MO 641102241 - Congressional District
- MO-05
- Phone
- 8167537600
Parent Company
MRIGLOBAL
Data Source
This profile is based on federal contract award data from USAspending.gov.
View on USAspending.gov